About The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis
During the past decade, The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
1996-11-01
2010-12-01
Completed
77
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
1998-11-01
2011-07-01
Completed
29
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
2001-05-01
2012-02-01
Completed
399
Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer
2001-10-01
2004-04-01
Completed
190
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
2001-12-01
2014-10-01
Completed
480
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
2002-09-01
2012-01-01
Completed
76
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis
According to Clinical.Site data, the most researched conditions in "The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis" are
"Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis" in a lesser frequency.
Clinical Trials Intervention Types at The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis
Most popular intervention types in "The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (3 trials), "Fenebrutinib" (2 trials), "Placebo" (1 trials), "Placebo matched to fenebrutinib" (1 trials) and "Placebo matched to ocrelizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis
The vast majority of trials in "The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis" are
4 trials for "All" genders.
Clinical Trials Status at The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis
Currently, there are NaN active trials in "The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".